Immunosuppressive Therapy for the Prevention of Restenosis After Coronary Artery Stent Implantation - IMPRESS

Description:

This double-blind, randomized, placebo-controlled trial evaluated the effects of oral prednisone on restenosis rate in patients with elevated C-reactive protein (CRP) levels 72 hours after coronary stent implantation.